Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.

Authors:
Hsu CK; Chen CY; Chen WC; Lai CC; Hung SH and 1 more

Journal:
Int J Antimicrob Agents

Publication Year: 2022

DOI:
10.1016/j.ijantimicag.2022.106545

PMCID:
PMC8817946

PMID:
35134505

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Antimicrob Agents

Abbreviation: Int J Antimicrob Agents

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis.
Chang YC; Chen YC; Huang CC and 7 more (2023) - Transparency Score: 4/6
Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis o…
Tian F; Feng Q; Chen Z. (2023) - Transparency Score: 4/6
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-ass…
Russo A; Bruni A; Gullì S and 12 more (2023) - Transparency Score: 3/6
Prescription of antibiotics by general practitioners for patients with a diagnosis of SARS- CoV-2 i…
Diamantis S; Youbong T; Strazzulla A and 7 more (2023) - Transparency Score: 3/6
The battle against fungi: lessons in antifungal stewardship from COVID 19 times
Kanj SS; Haddad SF; Meis JF and 9 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest None declared."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025